Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Feb;69(2):372–378. doi: 10.1038/bjc.1994.68

Hepatic arterial chemotherapy for metastatic colorectal carcinoma.

P G de Takats 1, D J Kerr 1, C J Poole 1, H W Warren 1, C S McArdle 1
PMCID: PMC1968698  PMID: 8297738

Abstract

In this review, the rationale of regional chemotherapy for treatment of hepatic metastases in advanced colorectal carcinoma is discussed. Pharmacokinetic principles and early clinical experience of hepatic arterial drug administration are summarised. The regional advantage of fluoropyrimidine compounds in this setting is well established, and recent evidence suggests that 5-fluorouracil (5-FU) is more efficacious than the analogue 5-fluoro-2'-deoxyuridine (FUDR). However, while significantly higher clinical response rates can be achieved with hepatic arterial infusion (HAI) chemotherapy compared with conventional intravenous drug administration, patient survival benefit is not significantly different. Several novel approaches to overcome the limitations of HAI therapy are currently being explored. These include concomitant use of biodegradable microspheres, which both slow tumour blood flow and enhance tumour drug uptake, and use of vasoactive agents to redistribute arterial blood flow towards tumours. In addition, novel chemotherapeutic agents which exploit unique biological characteristics of hepatic tumours are entering clinical trial.

Full text

PDF
372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. H., Kerr D. J., Cooke T. G., McArdle C. S. A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases. Br J Cancer. 1992 Jun;65(6):913–915. doi: 10.1038/bjc.1992.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson J. H., Kerr D. J., Setanoians A., Cooke T. G., McArdle C. S. A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid. Br J Cancer. 1992 Jan;65(1):133–135. doi: 10.1038/bjc.1992.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burton M. A., Gray B. N., Self G. W., Heggie J. C., Townsend P. S. Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II. Cancer Res. 1985 Nov;45(11 Pt 1):5390–5393. [PubMed] [Google Scholar]
  4. Chang A. E., Schneider P. D., Sugarbaker P. H., Simpson C., Culnane M., Steinberg S. M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987 Dec;206(6):685–693. doi: 10.1097/00000658-198712000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen H. S., Gross J. F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep. 1980 Jan;64(1):31–40. [PubMed] [Google Scholar]
  6. Collins J. M. Pharmacologic rationale for regional drug delivery. J Clin Oncol. 1984 May;2(5):498–504. doi: 10.1200/JCO.1984.2.5.498. [DOI] [PubMed] [Google Scholar]
  7. Dakhil S., Ensminger W., Cho K., Niederhuber J., Doan K., Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 1982 Aug 15;50(4):631–635. doi: 10.1002/1097-0142(19820815)50:4<631::aid-cncr2820500403>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Dedrick R. L., Myers C. E., Bungay P. M., DeVita V. T., Jr Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978 Jan;62(1):1–11. [PubMed] [Google Scholar]
  9. Ensminger W. D., Rosowsky A., Raso V., Levin D. C., Glode M., Come S., Steele G., Frei E., 3rd A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978 Nov;38(11 Pt 1):3784–3792. [PubMed] [Google Scholar]
  10. Finlay I. G., McArdle C. S. Occult hepatic metastases in colorectal carcinoma. Br J Surg. 1986 Sep;73(9):732–735. doi: 10.1002/bjs.1800730918. [DOI] [PubMed] [Google Scholar]
  11. Fortner J. G., Silva J. S., Golbey R. B., Cox E. B., Maclean B. J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984 Mar;199(3):306–316. doi: 10.1097/00000658-198403000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldberg J. A., Kerr D. J., Willmott N., McKillop J. H., McArdle C. S. Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer. 1988 Feb;57(2):186–189. doi: 10.1038/bjc.1988.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldberg J. A., Kerr D. J., Wilmott N., McKillop J. H., McArdle C. S. Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg. 1990 Nov;77(11):1238–1240. doi: 10.1002/bjs.1800771114. [DOI] [PubMed] [Google Scholar]
  14. Goldberg J. A., Murray T., Kerr D. J., Willmott N., Bessent R. G., McKillop J. H., McArdle C. S. The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer. 1991 Feb;63(2):308–310. doi: 10.1038/bjc.1991.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldberg J. A., Thomson J. A., Bradnam M. S., Fenner J., Bessent R. G., McKillop J. H., Kerr D. J., McArdle C. S. Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. Br J Cancer. 1991 Jul;64(1):114–119. doi: 10.1038/bjc.1991.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goldberg J. A., Thomson J. A., McCurrach G., Anderson J. H., Willmott N., Bessent R. G., McKillop J. H., McArdle C. S. Arteriovenous shunting in patients with colorectal liver metastases. Br J Cancer. 1991 Mar;63(3):466–468. doi: 10.1038/bjc.1991.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grage T. B., Vassilopoulos P. P., Shingleton W. W., Jubert A. V., Elias E. G., Aust J. B., Moss S. E. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery. 1979 Oct;86(4):550–555. [PubMed] [Google Scholar]
  18. Gyves J. W., Ensminger W. D., VanHarken D., Niederhuber J., Stetson P., Walker S. Improved regional selectivity of hepatic arterial mitomycin by starch microspheres. Clin Pharmacol Ther. 1983 Aug;34(2):259–265. doi: 10.1038/clpt.1983.163. [DOI] [PubMed] [Google Scholar]
  19. Hemingway D. M., Cooke T. G., McCurrach G., Bessent R. G., Carter R., McKillop J. H., McArdle C. S. Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer. Br J Cancer. 1992 May;65(5):781–782. doi: 10.1038/bjc.1992.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hohn D. C., Stagg R. J., Friedman M. A., Hannigan J. F., Jr, Rayner A., Ignoffo R. J., Acord P., Lewis B. J. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989 Nov;7(11):1646–1654. doi: 10.1200/JCO.1989.7.11.1646. [DOI] [PubMed] [Google Scholar]
  21. Huberman M. S. Comparison of systemic chemotherapy with hepatic arterial infusion in metastatic colorectal carcinoma. Semin Oncol. 1983 Jun;10(2):238–248. [PubMed] [Google Scholar]
  22. Hughes K. S., Simon R., Songhorabodi S., Adson M. A., Ilstrup D. M., Fortner J. G., Maclean B. J., Foster J. H., Daly J. M., Fitzherbert D. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986 Aug;100(2):278–284. [PubMed] [Google Scholar]
  23. Hunt T. M., Flowerdew A. D., Birch S. J., Williams J. D., Mullee M. A., Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg. 1990 Jul;77(7):779–782. doi: 10.1002/bjs.1800770720. [DOI] [PubMed] [Google Scholar]
  24. Jenkins S. A., Day D. W., Mooney B., Devitt P., Taylor I., Shields R. The effect of vasopressin and hepatic artery ligation on the blood supply to normal and metastatic liver tissue. Br J Cancer. 1984 Dec;50(6):785–791. doi: 10.1038/bjc.1984.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaelin W. G., Jr, Shrivastav S., Shand D. G., Jirtle R. L. Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res. 1982 Oct;42(10):3944–3949. [PubMed] [Google Scholar]
  26. Kato T., Nemoto R., Mori H., Kumagai I. Sustained-release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog. Cancer. 1980 Jul 1;46(1):14–21. doi: 10.1002/1097-0142(19800701)46:1<14::aid-cncr2820460103>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  27. Kemeny N. E. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! Important Adv Oncol. 1992:207–227. [PubMed] [Google Scholar]
  28. Kemeny N., Cohen A., Bertino J. R., Sigurdson E. R., Botet J., Oderman P. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer. 1990 Jun 1;65(11):2446–2450. doi: 10.1002/1097-0142(19900601)65:11<2446::aid-cncr2820651107>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  29. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987 Oct;107(4):459–465. doi: 10.7326/0003-4819-107-4-459. [DOI] [PubMed] [Google Scholar]
  30. Kemeny N., Niedzwiecki D., Shurgot B., Oderman P. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer. 1989 Feb 15;63(4):742–747. doi: 10.1002/1097-0142(19890215)63:4<742::aid-cncr2820630423>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  31. Konno T., Maeda H., Iwai K., Maki S., Tashiro S., Uchida M., Miyauchi Y. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer. 1984 Dec 1;54(11):2367–2374. doi: 10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  32. Konno T., Maeda H., Iwai K., Tashiro S., Maki S., Morinaga T., Mochinaga M., Hiraoka T., Yokoyama I. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol. 1983 Aug;19(8):1053–1065. doi: 10.1016/0277-5379(83)90028-7. [DOI] [PubMed] [Google Scholar]
  33. Leen E., Goldberg J. A., Robertson J., Sutherland G. R., McArdle C. S. The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer. 1991 Feb;63(2):323–325. doi: 10.1038/bjc.1991.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Maeda H., Seymour L. W., Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem. 1992 Sep-Oct;3(5):351–362. doi: 10.1021/bc00017a001. [DOI] [PubMed] [Google Scholar]
  35. Martin J. K., Jr, O'Connell M. J., Wieand H. S., Fitzgibbons R. J., Jr, Mailliard J. A., Rubin J., Nagorney D. M., Tschetter L. K., Krook J. E. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990 Aug;125(8):1022–1027. doi: 10.1001/archsurg.1990.01410200086013. [DOI] [PubMed] [Google Scholar]
  36. Mayer R. J. Chemotherapy for metastatic colorectal cancer. Cancer. 1992 Sep 1;70(5 Suppl):1414–1424. doi: 10.1002/1097-0142(19920901)70:3+<1414::aid-cncr2820701533>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  37. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol. 1992 Jun;10(6):896–903. doi: 10.1200/JCO.1992.10.6.896. [DOI] [PubMed] [Google Scholar]
  38. Niederhuber J. E., Ensminger W., Gyves J., Thrall J., Walker S., Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer. 1984 Mar 15;53(6):1336–1343. doi: 10.1002/1097-0142(19840315)53:6<1336::aid-cncr2820530620>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  39. O'Connell M. J. Is hepatic infusion of chemotherapy effective treatment for liver metastases? No! Important Adv Oncol. 1992:229–234. [PubMed] [Google Scholar]
  40. Rougier P., Ducreux M., Pignon J. P., Elias D., Tigaud J. M., Lumbroso J., Ruffie P., Lasser P. H. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. Eur J Cancer. 1991;27(10):1226–1230. doi: 10.1016/0277-5379(91)90086-s. [DOI] [PubMed] [Google Scholar]
  41. Rougier P., Laplanche A., Huguier M., Hay J. M., Ollivier J. M., Escat J., Salmon R., Julien M., Roullet Audy J. C., Gallot D. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992 Jul;10(7):1112–1118. doi: 10.1200/JCO.1992.10.7.1112. [DOI] [PubMed] [Google Scholar]
  42. Safi F., Bittner R., Roscher R., Schuhmacher K., Gaus W., Beger G. H. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer. 1989 Jul 15;64(2):379–387. doi: 10.1002/1097-0142(19890715)64:2<379::aid-cncr2820640207>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  43. Sasaki Y., Imaoka S., Hasegawa Y., Nakano S., Ishikawa O., Ohigashi H., Taniguchi K., Koyama H., Iwanaga T., Terasawa T. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer. 1985 Jan 15;55(2):311–316. doi: 10.1002/1097-0142(19850115)55:2<311::aid-cncr2820550202>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  44. Stagg R. J., Lewis B. J., Friedman M. A., Ignoffo R. J., Hohn D. C. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med. 1984 May;100(5):736–743. doi: 10.7326/0003-4819-100-5-736. [DOI] [PubMed] [Google Scholar]
  45. Wagner J. G., Gyves J. W., Stetson P. L., Walker-Andrews S. C., Wollner I. S., Cochran M. K., Ensminger W. D. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients. Cancer Res. 1986 Mar;46(3):1499–1506. [PubMed] [Google Scholar]
  46. Wagner J. S., Adson M. A., Van Heerden J. A., Adson M. H., Ilstrup D. M. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984 May;199(5):502–508. doi: 10.1097/00000658-198405000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Welch J. P., Donaldson G. A. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg. 1979 Apr;189(4):496–502. doi: 10.1097/00000658-197904000-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Widder K. J., Senyei A. E., Ranney D. F. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Adv Pharmacol Chemother. 1979;16:213–271. doi: 10.1016/s1054-3589(08)60246-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES